These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21083348)

  • 21. Utilization of DBS within drug discovery: a simple 2D-LC-MS/MS system to minimize blood- and paper-based matrix effects from FTA elute™ DBS.
    Clark GT; Haynes JJ
    Bioanalysis; 2011 Jun; 3(11):1253-70. PubMed ID: 21649501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human DBS sampling with LC-MS/MS for enantioselective determination of metoprolol and its metabolite O-desmethyl metoprolol.
    Liang X; Jiang H; Chen X
    Bioanalysis; 2010 Aug; 2(8):1437-48. PubMed ID: 21083344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
    Spooner N; Lad R; Barfield M
    Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
    Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
    Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis.
    Meesters RJ; Zhang J; van Huizen NA; Hooff GP; Gruters RA; Luider TM
    Bioanalysis; 2012 Aug; 4(16):2027-35. PubMed ID: 22946918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies.
    Burnett JE
    Bioanalysis; 2011 May; 3(10):1099-107. PubMed ID: 21585305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes.
    Dillen L; Loomans T; Van de Perre G; Versweyveld D; Wuyts K; de Zwart L
    Bioanalysis; 2014 Feb; 6(3):293-306. PubMed ID: 24471951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite.
    Déglon J; Thomas A; Daali Y; Lauer E; Samer C; Desmeules J; Dayer P; Mangin P; Staub C
    J Pharm Biomed Anal; 2011 Jan; 54(2):359-67. PubMed ID: 20864289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capillary microsampling in the regulatory environment: validation and use of bioanalytical capillary microsampling methods.
    Nilsson LB; Ahnoff M; Jonsson O
    Bioanalysis; 2013 Mar; 5(6):731-8. PubMed ID: 23484790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
    Bowen CL; Hemberger MD; Kehler JR; Evans CA
    Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates.
    Denniff P; Spooner N
    Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of capillary high performance liquid chromatography with electrospray mass spectrometry for the analysis of small volume blood samples from serially bled mice to determine the pharmacokinetics of early discovery compounds.
    Fraser IJ; Dear GJ; Plumb R; L'Affineur M; Fraser D; Skippen AJ
    Rapid Commun Mass Spectrom; 1999; 13(23):2366-75. PubMed ID: 10567936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
    Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
    Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
    Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
    Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
    Edelbroek PM; van der Heijden J; Stolk LM
    Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioanalytical implementation of plasma capillary microsampling: small hurdles, large gains.
    Spreadborough MJ; Day J; Jackson-Addie K; Wilson A
    Bioanalysis; 2013 Jun; 5(12):1485-9. PubMed ID: 23795926
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.
    Michi M; Ferrari L
    Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.